Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Also in development is CagriSema , a new type of medication for type 2 diabetes and weight management that combines semaglutide and cagrilintide
If symptoms are particularly troublesome, your doctor may recommend: Slower dose escalation than standard protocols Temporary dose reduction Switching to a different GLP-1 agonist, as individual responses vary Short-term use of anti-diarrhoeal medications such as loperamide for acute episodes, though this should only be done under medical supervision and avoided if you have blood in your stool, fever, or suspected infection If you're also taking insulin or sulfonylureas, monitor your blood glucose more frequently during periods of reduced appetite or diarrhoea, as you may need dose adjustments to prevent hypoglycaemia
[1] [3] The medication can be administered in the abdomen, thigh, or upper arm, with injection site rotation recommended to minimize local reactions
The 12 mg dose lowered the standard blood-sugar control marker (HbA1c) by approximately 2.0 percentage points at 24 weeks, exceeding dulaglutide's roughly 1.4 percentage point reduction
patients experiencing severe abdominal pain, vomiting, or changes in kidney function should seek immediate medical evaluation
They can reduce or prevent these symptoms in a number of ways
